GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PolyPeptide Group AG (XSWX:PPGN) » Definitions » Construction In Progress

PolyPeptide Group AG (XSWX:PPGN) Construction In Progress : CHF86.0 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is PolyPeptide Group AG Construction In Progress?

PolyPeptide Group AG's quarterly construction in progress declined from Dec. 2022 (CHF97.3 Mil) to Jun. 2023 (CHF0.0 Mil) but then increased from Jun. 2023 (CHF0.0 Mil) to Dec. 2023 (CHF86.0 Mil).

PolyPeptide Group AG's annual construction in progress increased from Dec. 2021 (CHF91.0 Mil) to Dec. 2022 (CHF97.3 Mil) but then declined from Dec. 2022 (CHF97.3 Mil) to Dec. 2023 (CHF86.0 Mil).

PolyPeptide Group AG Construction In Progress Historical Data

The historical data trend for PolyPeptide Group AG's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PolyPeptide Group AG Construction In Progress Chart

PolyPeptide Group AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Construction In Progress
Get a 7-Day Free Trial 24.12 53.57 90.95 97.35 85.98

PolyPeptide Group AG Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only 90.95 - 97.35 - 85.98

PolyPeptide Group AG Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

PolyPeptide Group AG (XSWX:PPGN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PolyPeptide Group AG (XSWX:PPGN) » Definitions » Construction In Progress
Comparable Companies
BSP:SNCI11 BSP:OPCT3 BSP:ARML3 BSP:VAMO3 BSP:MILS3 BSP:VLID3 BSP:RENT3 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NBIX NSE:DIVISLAB BOM:500124
Traded in Other Exchanges
PPGNz:UK
Address
Neuhofstrasse 24, Baar, Zug, CHE, 6340
Website
https://www.polypeptide.com
PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives a majority of its revenue from Europe and Asia.

PolyPeptide Group AG (XSWX:PPGN) Headlines

No Headlines